awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36429723-816F3C77-8329-4AAF-A269-B24FBDF9EF57
Q36429723-816F3C77-8329-4AAF-A269-B24FBDF9EF57
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36429723-816F3C77-8329-4AAF-A269-B24FBDF9EF57
Advances in the treatment for haematological malignancies.
P2860
Q36429723-816F3C77-8329-4AAF-A269-B24FBDF9EF57
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36429723-816F3C77-8329-4AAF-A269-B24FBDF9EF57
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e6e3088eff7beae0e44637877c5b50bbd3a5edb
P2860
Report of a European consensus workshop to develop recommendations for the optimal use of (90)Y-ibritumomab tiuxetan (Zevalin) in lymphoma.